Your browser doesn't support javascript.
loading
Humoral and T-Cell Response to SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis Treated With Ocrelizumab.
Brill, Livnat; Rechtman, Ariel; Zveik, Omri; Haham, Nitzan; Oiknine-Djian, Esther; Wolf, Dana G; Levin, Netta; Raposo, Catarina; Vaknin-Dembinsky, Adi.
Afiliação
  • Brill L; Faculty of Medicine, Hebrew University of Jerusalem, Department of Neurology and Laboratory of Neuroimmunology and the Agnes-Ginges Center for Neurogenetics, Hadassah Medical Center, Ein-Kerem, Jerusalem, Israel.
  • Rechtman A; Faculty of Medicine, Hebrew University of Jerusalem, Department of Neurology and Laboratory of Neuroimmunology and the Agnes-Ginges Center for Neurogenetics, Hadassah Medical Center, Ein-Kerem, Jerusalem, Israel.
  • Zveik O; Faculty of Medicine, Hebrew University of Jerusalem, Department of Neurology and Laboratory of Neuroimmunology and the Agnes-Ginges Center for Neurogenetics, Hadassah Medical Center, Ein-Kerem, Jerusalem, Israel.
  • Haham N; Faculty of Medicine, Hebrew University of Jerusalem, Department of Neurology and Laboratory of Neuroimmunology and the Agnes-Ginges Center for Neurogenetics, Hadassah Medical Center, Ein-Kerem, Jerusalem, Israel.
  • Oiknine-Djian E; Clinical Virology Unit, Hadassah Hebrew University Medical Center, Jerusalem, Israel.
  • Wolf DG; Lautenberg Center for General and Tumor Immunology, The Hebrew University Faculty of Medicine, Jerusalem, Israel.
  • Levin N; Clinical Virology Unit, Hadassah Hebrew University Medical Center, Jerusalem, Israel.
  • Raposo C; Lautenberg Center for General and Tumor Immunology, The Hebrew University Faculty of Medicine, Jerusalem, Israel.
  • Vaknin-Dembinsky A; Faculty of Medicine, Hebrew University of Jerusalem, Department of Neurology and Laboratory of Neuroimmunology and the Agnes-Ginges Center for Neurogenetics, Hadassah Medical Center, Ein-Kerem, Jerusalem, Israel.
JAMA Neurol ; 78(12): 1510-1514, 2021 12 01.
Article em En | MEDLINE | ID: mdl-34554197
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 4_TD Base de dados: MEDLINE Assunto principal: Linfócitos T / Imunidade Humoral / Anticorpos Monoclonais Humanizados / Vacinas contra COVID-19 / Fatores Imunológicos / Esclerose Múltipla Tipo de estudo: Guideline / Prognostic_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: JAMA Neurol Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 4_TD Base de dados: MEDLINE Assunto principal: Linfócitos T / Imunidade Humoral / Anticorpos Monoclonais Humanizados / Vacinas contra COVID-19 / Fatores Imunológicos / Esclerose Múltipla Tipo de estudo: Guideline / Prognostic_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: JAMA Neurol Ano de publicação: 2021 Tipo de documento: Article